Addex Therapeutics Ltd revenue for the last year amounted to 1.80 M USD, the most of which — 1.83 M USD — came from its highest performing source at the moment, Small-molecule Pharmaceutical Products, the year earlier bringing 1.51 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought Addex Therapeutics Ltd 1.83 M USD, and the year before that — 1.51 M USD.